NCT01010126 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 58
- group Id
- BG002
- value
- 27
- group Id
- BG003
- value
- 57
- group Id
- BG004
- value
- 58
- group Id
- BG005
- value
- 24
- group Id
- BG006
- value
- 250
- units
- Participants
- groups
- description
- Patients receive 25 mg temsirolimus IV on days 1, 8, 15, and 22, and 10 mg/kg bevacizumab IV over 30-90 minutes on days 1 and 15. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG000
- title
- Endometrial Cohort
- description
- Patients receive 25 mg temsirolimus IV on days 1, 8, 15, and 22, and 10 mg/kg bevacizumab IV over 30-90 minutes on days 1 and 15. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG001
- title
- Ovarian Cohort
- description
- Patients receive 25 mg temsirolimus IV on days 1, 8, 15, and 22, and 10 mg/kg bevacizumab IV over 30-90 minutes on days 1 and 15. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG002
- title
- Hepatocellular Cohort
- description
- Patients receive 25 mg temsirolimus IV on days 1, 8, 15, and 22, and 10 mg/kg bevacizumab IV over 30-90 minutes on days 1 and 15. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG003
- title
- Carcinoid Cohort
- description
- Patients receive 25 mg temsirolimus IV on days 1, 8, 15, and 22, and 10 mg/kg bevacizumab IV over 30-90 minutes on days 1 and 15. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG004
- title
- Islet Cell (Double Agent) Cohort
- description
- Patients receive 10 mg/kg bevacizumab IV over 30-90 minutes on days 1 and 15. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG005
- title
- Islet Cell (Bevacizumab-only) Cohort
- description
- Total of all reporting groups
- id
- BG006
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 40
- upper Limit
- 80
- value
- 60
- group Id
- BG001
- lower Limit
- 35
- upper Limit
- 82
- value
- 62.5
- group Id
- BG002
- lower Limit
- 31
- upper Limit
- 74
- value
- 59
- group Id
- BG003
- lower Limit
- 35
- upper Limit
- 89
- value
- 62
- group Id
- BG004
- lower Limit
- 29
- upper Limit
- 81
- value
- 58.5
- group Id
- BG005
- lower Limit
- 40
- upper Limit
- 78
- value
- 54.5
- group Id
- BG006
- lower Limit
- 29
- upper Limit
- 89
- value
- 60
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 58
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 31
- group Id
- BG004
- value
- 29
- group Id
- BG005
- value
- 10
- group Id
- BG006
- value
- 159
- title
- Female
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 22
- group Id
- BG003
- value
- 26
- group Id
- BG004
- value
- 29
- group Id
- BG005
- value
- 14
- group Id
- BG006
- value
- 91
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 11
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 54
- group Id
- BG002
- value
- 25
- group Id
- BG003
- value
- 54
- group Id
- BG004
- value
- 57
- group Id
- BG005
- value
- 22
- group Id
- BG006
- value
- 231
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 8
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 8
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 6
- group Id
- BG004
- value
- 8
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 24
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 22
- group Id
- BG001
- value
- 49
- group Id
- BG002
- value
- 22
- group Id
- BG003
- value
- 49
- group Id
- BG004
- value
- 50
- group Id
- BG005
- value
- 20
- group Id
- BG006
- value
- 212
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 5
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 34
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 14
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 63
- title
- Canada
- categories
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 19
- group Id
- BG003
- value
- 55
- group Id
- BG004
- value
- 44
- group Id
- BG005
- value
- 24
- group Id
- BG006
- value
- 187
- title
- United States
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 58
- group Id
- BG002
- value
- 27
- group Id
- BG003
- value
- 57
- group Id
- BG004
- value
- 58
- group Id
- BG005
- value
- 24
- group Id
- BG006
- value
- 250
- units
- Participants
- groups
- description
- Patients receive 25 mg temsirolimus IV on days 1, 8, 15, and 22, and 10 mg/kg bevacizumab IV over 30-90 minutes on days 1 and 15. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG000
- title
- Endometrial Cohort
- description
- Patients receive 25 mg temsirolimus IV on days 1, 8, 15, and 22, and 10 mg/kg bevacizumab IV over 30-90 minutes on days 1 and 15. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG001
- title
- Ovarian Cohort
- description
- Patients receive 25 mg temsirolimus IV on days 1, 8, 15, and 22, and 10 mg/kg bevacizumab IV over 30-90 minutes on days 1 and 15. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG002
- title
- Hepatocellular Cohort
- description
- Patients receive 25 mg temsirolimus IV on days 1, 8, 15, and 22, and 10 mg/kg bevacizumab IV over 30-90 minutes on days 1 and 15. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG003
- title
- Carcinoid Cohort
- description
- Patients receive 25 mg temsirolimus IV on days 1, 8, 15, and 22, and 10 mg/kg bevacizumab IV over 30-90 minutes on days 1 and 15. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG004
- title
- Islet Cell (Double Agent) Cohort
- description
- Patients receive 10 mg/kg bevacizumab IV over 30-90 minutes on days 1 and 15. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
- id
- BG005
- title
- Islet Cell (Bevacizumab-only) Cohort
- description
- Total of all reporting groups
- id
- BG006
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 40
- upper Limit
- 80
- value
- 60
- group Id
- BG001
- lower Limit
- 35
- upper Limit
- 82
- value
- 62.5
- group Id
- BG002
- lower Limit
- 31
- upper Limit
- 74
- value
- 59
- group Id
- BG003
- lower Limit
- 35
- upper Limit
- 89
- value
- 62
- group Id
- BG004
- lower Limit
- 29
- upper Limit
- 81
- value
- 58.5
- group Id
- BG005
- lower Limit
- 40
- upper Limit
- 78
- value
- 54.5
- group Id
- BG006
- lower Limit
- 29
- upper Limit
- 89
- value
- 60
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 58
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 31
- group Id
- BG004
- value
- 29
- group Id
- BG005
- value
- 10
- group Id
- BG006
- value
- 159
- title
- Female
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 22
- group Id
- BG003
- value
- 26
- group Id
- BG004
- value
- 29
- group Id
- BG005
- value
- 14
- group Id
- BG006
- value
- 91
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 11
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 54
- group Id
- BG002
- value
- 25
- group Id
- BG003
- value
- 54
- group Id
- BG004
- value
- 57
- group Id
- BG005
- value
- 22
- group Id
- BG006
- value
- 231
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 8
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 8
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 6
- group Id
- BG004
- value
- 8
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 24
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 22
- group Id
- BG001
- value
- 49
- group Id
- BG002
- value
- 22
- group Id
- BG003
- value
- 49
- group Id
- BG004
- value
- 50
- group Id
- BG005
- value
- 20
- group Id
- BG006
- value
- 212
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 5
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 34
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 14
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 63
- title
- Canada
- categories
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 19
- group Id
- BG003
- value
- 55
- group Id
- BG004
- value
- 44
- group Id
- BG005
- value
- 24
- group Id
- BG006
- value
- 187
- title
- United States
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle